265 related articles for article (PubMed ID: 27494872)
21. MicroRNAs Change the Landscape of Cancer Resistance.
Zhu J; Zhu W; Wu W
Methods Mol Biol; 2018; 1699():83-89. PubMed ID: 29086370
[TBL] [Abstract][Full Text] [Related]
22. Role of miR-155 in drug resistance of breast cancer.
Yu DD; Lv MM; Chen WX; Zhong SL; Zhang XH; Chen L; Ma TF; Tang JH; Zhao JH
Tumour Biol; 2015 Mar; 36(3):1395-401. PubMed ID: 25744731
[TBL] [Abstract][Full Text] [Related]
23. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
[TBL] [Abstract][Full Text] [Related]
24. The role and mechanisms of action of microRNAs in cancer drug resistance.
Si W; Shen J; Zheng H; Fan W
Clin Epigenetics; 2019 Feb; 11(1):25. PubMed ID: 30744689
[TBL] [Abstract][Full Text] [Related]
25. Implication of microRNAs in drug resistance for designing novel cancer therapy.
Sarkar FH; Li Y; Wang Z; Kong D; Ali S
Drug Resist Updat; 2010 Jun; 13(3):57-66. PubMed ID: 20236855
[TBL] [Abstract][Full Text] [Related]
26. miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.
Corcoran C; Rani S; O'Driscoll L
Prostate; 2014 Sep; 74(13):1320-34. PubMed ID: 25053345
[TBL] [Abstract][Full Text] [Related]
27. [Mechanisms of drug resistance and sensitivity concerning novel agents for multiple myeloma].
Tokuhira M
Rinsho Ketsueki; 2016 May; 57(5):563-74. PubMed ID: 27263780
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs and cancer resistance: A new molecular plot.
Fanini F; Fabbri M
Clin Pharmacol Ther; 2016 May; 99(5):485-93. PubMed ID: 26875151
[TBL] [Abstract][Full Text] [Related]
29. The potential of miRNAs as biomarkers for multiple myeloma.
Rocci A; Hofmeister CC; Pichiorri F
Expert Rev Mol Diagn; 2014 Nov; 14(8):947-59. PubMed ID: 25098410
[TBL] [Abstract][Full Text] [Related]
30. Review of miR-200b and cancer chemosensitivity.
Feng B; Wang R; Chen LB
Biomed Pharmacother; 2012 Sep; 66(6):397-402. PubMed ID: 22795796
[TBL] [Abstract][Full Text] [Related]
31. The role of circulating miRNAs in multiple myeloma.
Zhang J; Xiao X; Liu J
Sci China Life Sci; 2015 Dec; 58(12):1262-9. PubMed ID: 26607481
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-induced drug resistance in gastric cancer.
Dehghanzadeh R; Jadidi-Niaragh F; Gharibi T; Yousefi M
Biomed Pharmacother; 2015 Aug; 74():191-9. PubMed ID: 26349984
[TBL] [Abstract][Full Text] [Related]
33. The role of exosomes and miRNAs in drug-resistance of cancer cells.
Bach DH; Hong JY; Park HJ; Lee SK
Int J Cancer; 2017 Jul; 141(2):220-230. PubMed ID: 28240776
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs in melanoma development and resistance to target therapy.
Fattore L; Costantini S; Malpicci D; Ruggiero CF; Ascierto PA; Croce CM; Mancini R; Ciliberto G
Oncotarget; 2017 Mar; 8(13):22262-22278. PubMed ID: 28118616
[TBL] [Abstract][Full Text] [Related]
35. The emerging role of microRNAs in resistance to lung cancer treatments.
MacDonagh L; Gray SG; Finn SP; Cuffe S; O'Byrne KJ; Barr MP
Cancer Treat Rev; 2015 Feb; 41(2):160-9. PubMed ID: 25592062
[TBL] [Abstract][Full Text] [Related]
36. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
37. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.
Humphries B; Yang C
Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells.
Husted S; Søkilde R; Rask L; Cirera S; Busk PK; Eriksen J; Litman T
Mol Pharm; 2011 Dec; 8(6):2055-62. PubMed ID: 21899346
[TBL] [Abstract][Full Text] [Related]
39. MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment.
Raimondi L; De Luca A; Morelli E; Giavaresi G; Tagliaferri P; Tassone P; Amodio N
Biomed Res Int; 2016; 2016():6504593. PubMed ID: 26881223
[TBL] [Abstract][Full Text] [Related]
40. miRNAs driving diagnosis, progression, and drug resistance in multiple myeloma.
Elkady MA; Yehia AM; Elsakka EGE; Abulsoud AI; Abdelmaksoud NM; Elshafei A; Elkhawaga SY; Ismail A; Mokhtar MM; El-Mahdy HA; Hegazy M; Elballal MS; Mohammed OA; El-Husseiny HM; Midan HM; El-Dakroury WA; Zewail MB; Abdel Mageed SS; Doghish AS
Pathol Res Pract; 2023 Aug; 248():154704. PubMed ID: 37499518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
